A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain

Clinical trial NCT01429051 · COMPLETED

Trial details

NCT number: NCT01429051
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Break Through Pain Cancer

Start date: 2011-08-01
Primary completion: 2013-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.